Brief: Harpoon Receives Notice Of Delisting From Nasdaq
Dec 1 (Reuters) - Harpoon Therapeutics Inc HARP.O :
* ON NOV 29, CO RECEIVED NOTICE OF DELISTING OR FAILURE TO
SATISFY
A CONTINUED LISTING RULE OR STANDARD FROM NASDAQ
Further company coverage: HARP.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Harpoon Therapeutics
See all newsBrief: Harpoon Therapeutics Receives 17 Additional Demands Seeking Disclosures in Proxy Statement
U.S. RESEARCH ROUNDUP-Axonics, BlackRock, Credit Acceptance
U.S. STOCKS ON THE MOVE-Core & Main, Commercial Metals, Equifax
U.S. STOCKS ON THE MOVE-Toll Brothers, American Eagle Outfitters, Twilio
Wrapup 1: Drugmakers kick off industry conference with two cancer deals